FDA recall D-1190-2018

Baxter Healthcare Corporation · Class II · drug

Product

0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31

Reason for recall

cGMP Deviation

Distribution

Nationwide.

Key facts

Status
Terminated
Initiation date
2018-09-06
Report date
2018-09-26
Termination date
2020-10-01
Voluntary/Mandated
Voluntary: Firm initiated
Location
Deerfield, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1190-2018